Format

Send to

Choose Destination
See comment in PubMed Commons below
World J Gastrointest Pharmacol Ther. 2016 Nov 6;7(4):490-502.

Treatment of pregnant women with a diagnosis of inflammatory bowel disease.

Author information

  • 1Sule Poturoglu, Asli Ciftcibasi Ormeci, Ali Erkan Duman, Department of Gastroenterology, Haseki Training and Research Hospital, 34096 Istanbul, Turkey.

Abstract

The frequency of diagnosis of inflammatory bowel disease (IBD) has increased in younger populations. For this reason, pregnancy in patients with IBD is a topic of interest, warranting additional focus on disease management during this period. The main objective of this article is to summarize the latest findings and guidelines on the management of potential problems from pregnancy to the breastfeeding stage. Fertility is decreased in patients with active IBD. Disease remission prior to conception will likely decrease the rate of pregnancy-related complications. Most of the drugs used for IBD treatment are safe during both pregnancy and breastfeeding. Two exceptions are methotrexate and thalidomide, which are contraindicated in pregnancy. Anti-tumor necrosis factor agents are not advised during the third trimester as they exhibit increased transplacental transmission and potentially cause immunosuppression in the fetus. Radiological and endoscopic examinations and surgical interventions should be performed only when absolutely necessary. Surgery increases the fetal mortality rate. The delivery method should be determined with consideration of the disease site and presence of progression or flare up. Treatment planning should be a collaborative effort among the gastroenterologist, obstetrician, colorectal surgeon and patient.

KEYWORDS:

Biologics; Breastfeeding; Immunomodulators; Inflammatory bowel disease; Pregnancy; Treatment

PMID:
27867682
PMCID:
PMC5095568
DOI:
10.4292/wjgpt.v7.i4.490
[PubMed - in process]
Free PMC Article

Publication Types

Publication Types

PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Baishideng Publishing Group Inc. Icon for PubMed Central
    Loading ...
    Support Center